| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF728 ZNF875 ESR2 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 2.84e-14 | 1412 | 49 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF728 ZNF875 ESR2 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 5.69e-14 | 1459 | 49 | 23 | GO:0000977 |
| GeneOntologyMolecularFunction | alpha-amylase activity | 7.21e-14 | 5 | 49 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.32e-13 | 6 | 49 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF728 ESR2 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF284 ZIC3 ZNF445 | 3.32e-12 | 1244 | 49 | 20 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF728 ESR2 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF284 ZIC3 ZNF445 | 4.92e-12 | 1271 | 49 | 20 | GO:0000987 |
| GeneOntologyMolecularFunction | chloride ion binding | 3.09e-10 | 16 | 49 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | CTCFL ZNF628 ESR2 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZNF112 ZIC3 ZNF445 | 7.54e-09 | 560 | 49 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | CTCFL ZNF628 ESR2 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZNF112 ZIC3 ZNF445 | 8.49e-09 | 566 | 49 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 5.27e-06 | 103 | 49 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.60e-06 | 16 | 49 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.13e-05 | 749 | 49 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.79e-05 | 21 | 49 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.69e-05 | 144 | 49 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 3.83e-04 | 12 | 49 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.10e-03 | 320 | 49 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.19e-03 | 326 | 49 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.19e-03 | 85 | 49 | 3 | GO:0038024 | |
| Domain | - | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 1.30e-20 | 679 | 49 | 23 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 2.06e-20 | 693 | 49 | 23 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 2.12e-20 | 694 | 49 | 23 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 2.50e-19 | 775 | 49 | 23 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 2.65e-19 | 777 | 49 | 23 | PS00028 |
| Domain | Znf_C2H2-like | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 4.53e-19 | 796 | 49 | 23 | IPR015880 |
| Domain | Znf_C2H2 | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 5.81e-19 | 805 | 49 | 23 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 6.31e-19 | 808 | 49 | 23 | SM00355 |
| Domain | KRAB | ZNF430 ZNF100 ZNF562 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF284 ZNF248 ZNF445 | 9.21e-19 | 369 | 49 | 18 | SM00349 |
| Domain | KRAB | ZNF430 ZNF100 ZNF562 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF284 ZNF248 ZNF445 | 9.66e-19 | 370 | 49 | 18 | IPR001909 |
| Domain | KRAB | ZNF430 ZNF100 ZNF562 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZNF112 ZNF284 ZNF248 ZNF445 | 1.62e-17 | 358 | 49 | 17 | PS50805 |
| Domain | KRAB | ZNF430 ZNF100 ZNF562 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZNF112 ZNF284 ZNF248 ZNF445 | 1.62e-17 | 358 | 49 | 17 | PF01352 |
| Domain | zf-C2H2_6 | ZNF100 ZNF562 ZNF155 ZNF728 ZNF431 ZNF721 ZNF736 ZNF224 ZNF225 ZNF227 ZNF284 ZNF445 | 2.19e-11 | 314 | 49 | 12 | PF13912 |
| Domain | Aamy_C | 4.18e-11 | 4 | 49 | 4 | SM00632 | |
| Domain | Alpha_amylase | 4.18e-11 | 4 | 49 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 2.09e-10 | 5 | 49 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.09e-10 | 5 | 49 | 4 | IPR006048 | |
| Domain | Aamy | 1.45e-09 | 7 | 49 | 4 | SM00642 | |
| Domain | Alpha-amylase | 1.45e-09 | 7 | 49 | 4 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 1.45e-09 | 7 | 49 | 4 | IPR006047 | |
| Domain | A-amylase_C | 1.70e-08 | 3 | 49 | 3 | IPR031319 | |
| Domain | Ldl_recept_b | 4.10e-08 | 14 | 49 | 4 | PF00058 | |
| Domain | LDLRB | 4.10e-08 | 14 | 49 | 4 | PS51120 | |
| Domain | Glyco_hydro_b | 5.59e-08 | 15 | 49 | 4 | IPR013780 | |
| Domain | LY | 5.59e-08 | 15 | 49 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.59e-08 | 15 | 49 | 4 | IPR000033 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.27e-07 | 46 | 49 | 5 | IPR011042 | |
| Domain | Glyco_hydro_13 | 3.38e-07 | 6 | 49 | 3 | IPR015902 | |
| Domain | Glyco_hydro_catalytic_dom | 2.89e-06 | 38 | 49 | 4 | IPR013781 | |
| Domain | - | 3.21e-06 | 39 | 49 | 4 | 2.120.10.30 | |
| Domain | - | 6.05e-06 | 14 | 49 | 3 | 2.60.40.1180 | |
| Domain | ASX_HYDROXYL | 6.29e-06 | 100 | 49 | 5 | PS00010 | |
| Domain | DUF5050 | 6.74e-06 | 2 | 49 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.74e-06 | 2 | 49 | 2 | PF16472 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.37e-06 | 106 | 49 | 5 | IPR000152 | |
| Domain | Glycoside_hydrolase_SF | 1.11e-05 | 53 | 49 | 4 | IPR017853 | |
| Domain | EGF_CA | 1.66e-05 | 122 | 49 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.80e-05 | 124 | 49 | 5 | IPR001881 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | IPR026823 | |
| Domain | cEGF | 4.23e-05 | 26 | 49 | 3 | PF12662 | |
| Domain | Growth_fac_rcpt_ | 5.40e-05 | 156 | 49 | 5 | IPR009030 | |
| Domain | EGF_CA | 7.58e-05 | 86 | 49 | 4 | PF07645 | |
| Domain | - | 1.05e-04 | 35 | 49 | 3 | 3.20.20.80 | |
| Domain | EGF_Ca-bd_CS | 1.21e-04 | 97 | 49 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.31e-04 | 99 | 49 | 4 | PS01187 | |
| Domain | LDLR_class-A_CS | 1.57e-04 | 40 | 49 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 2.23e-04 | 45 | 49 | 3 | PF00057 | |
| Domain | - | 2.38e-04 | 46 | 49 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.70e-04 | 48 | 49 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.87e-04 | 49 | 49 | 3 | IPR002172 | |
| Domain | LDLa | 2.87e-04 | 49 | 49 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.87e-04 | 49 | 49 | 3 | PS50068 | |
| Domain | EGF | 3.31e-04 | 126 | 49 | 4 | PF00008 | |
| Domain | EGF_3 | 3.67e-04 | 235 | 49 | 5 | PS50026 | |
| Domain | EGF | 3.67e-04 | 235 | 49 | 5 | SM00181 | |
| Domain | EGF-like_dom | 4.78e-04 | 249 | 49 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 5.92e-04 | 261 | 49 | 5 | IPR013032 | |
| Domain | EGF_2 | 6.34e-04 | 265 | 49 | 5 | PS01186 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.79e-03 | 24 | 49 | 2 | IPR013273 | |
| Domain | EGF_1 | 4.44e-03 | 255 | 49 | 4 | PS00022 | |
| Domain | SCAN | 9.49e-03 | 56 | 49 | 2 | SM00431 | |
| Domain | SCAN_BOX | 1.02e-02 | 58 | 49 | 2 | PS50804 | |
| Domain | SCAN | 1.02e-02 | 58 | 49 | 2 | PF02023 | |
| Domain | SCAN_dom | 1.02e-02 | 58 | 49 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.05e-02 | 59 | 49 | 2 | IPR008916 | |
| Domain | TSP_1 | 1.19e-02 | 63 | 49 | 2 | PF00090 | |
| Domain | TSP1 | 1.26e-02 | 65 | 49 | 2 | SM00209 | |
| Domain | TSP1_rpt | 1.26e-02 | 65 | 49 | 2 | IPR000884 | |
| Domain | TSP1 | 1.26e-02 | 65 | 49 | 2 | PS50092 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.29e-11 | 9 | 45 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.20e-10 | 11 | 45 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 8.50e-09 | 23 | 45 | 5 | M27790 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF430 ZNF100 ZNF562 ZNF155 ZNF875 ESR2 EHMT1 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF248 ZNF445 | 1.30e-08 | 1387 | 45 | 19 | M734 |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.45e-08 | 28 | 45 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.13e-07 | 52 | 45 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.68e-06 | 8 | 45 | 3 | MM14717 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ESR2 EHMT1 ZNF205 ZNF721 ZNF736 ZNF101 ZSCAN25 ZNF112 ZNF284 ZNF248 ZNF445 | 2.16e-05 | 768 | 45 | 11 | MM14851 |
| Pathway | REACTOME_DIGESTION | 3.88e-05 | 21 | 45 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 6.66e-05 | 25 | 45 | 3 | MM15557 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ESR2 EHMT1 ZNF205 ZNF721 ZNF736 ZNF101 ZSCAN25 ZNF112 ZNF284 ZNF248 ZNF445 | 2.83e-04 | 1022 | 45 | 11 | MM15436 |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 7.60e-04 | 13 | 45 | 2 | M42551 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 1.02e-03 | 15 | 45 | 2 | M42552 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 1.48e-03 | 18 | 45 | 2 | M42559 | |
| Pathway | WP_STATIN_PATHWAY | 1.65e-03 | 19 | 45 | 2 | MM15868 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 3.32e-14 | 6 | 51 | 5 | 6608795 | |
| Pubmed | 3.32e-14 | 6 | 51 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 3.32e-14 | 6 | 51 | 5 | 2788608 | |
| Pubmed | 3.32e-14 | 6 | 51 | 5 | 2081604 | ||
| Pubmed | 3.32e-14 | 6 | 51 | 5 | 15286789 | ||
| Pubmed | ZNF430 ZNF100 ZNF562 ZNF728 EHMT1 ZNF721 ZNF736 ZNF101 ZNF227 ZNF445 | 1.20e-13 | 181 | 51 | 10 | 37372979 | |
| Pubmed | 2.80e-13 | 20 | 51 | 6 | 12743021 | ||
| Pubmed | 3.09e-13 | 8 | 51 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 4.10e-12 | 4 | 51 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 4.10e-12 | 4 | 51 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 4.10e-12 | 4 | 51 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 4.10e-12 | 4 | 51 | 4 | 26098870 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 6160849 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 4.10e-12 | 4 | 51 | 4 | 4745489 | |
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 4.10e-12 | 4 | 51 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 4.10e-12 | 4 | 51 | 4 | 94264 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 3872721 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 4.10e-12 | 4 | 51 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 4.10e-12 | 4 | 51 | 4 | 6207174 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 2410924 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 4.10e-12 | 4 | 51 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 4.10e-12 | 4 | 51 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 4.10e-12 | 4 | 51 | 4 | 2987507 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 4.10e-12 | 4 | 51 | 4 | 2332419 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 4.10e-12 | 4 | 51 | 4 | 6162108 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 16152770 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 2423416 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 4.10e-12 | 4 | 51 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 4.10e-12 | 4 | 51 | 4 | 2989529 | |
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.05e-11 | 5 | 51 | 4 | 34276419 | |
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 6176569 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.05e-11 | 5 | 51 | 4 | 8661735 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 6.14e-11 | 6 | 51 | 4 | 7859283 | |
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 2002257 | ||
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 2450406 | ||
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 6.14e-11 | 6 | 51 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 6.14e-11 | 6 | 51 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 6.14e-11 | 6 | 51 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 6.14e-11 | 6 | 51 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.43e-10 | 7 | 51 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.43e-10 | 7 | 51 | 4 | 2451911 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 7949740 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 6160178 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 8604219 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 8666240 | ||
| Pubmed | 2.86e-10 | 8 | 51 | 4 | 2040456 | ||
| Pubmed | 2.86e-10 | 8 | 51 | 4 | 3038891 | ||
| Pubmed | 2.86e-10 | 8 | 51 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 2.86e-10 | 8 | 51 | 4 | 6200103 | |
| Pubmed | 2.86e-10 | 8 | 51 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 2.86e-10 | 8 | 51 | 4 | 7523515 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 93520 | ||
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 9121556 | ||
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 2897103 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 23449223 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 2565740 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 7608209 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 1617215 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.34e-09 | 11 | 51 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.34e-09 | 11 | 51 | 4 | 8589528 | |
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 2903254 | ||
| Pubmed | 2.01e-09 | 12 | 51 | 4 | 8144363 | ||
| Pubmed | 2.01e-09 | 12 | 51 | 4 | 11891983 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 2.90e-09 | 13 | 51 | 4 | 7829080 | |
| Pubmed | 2.90e-09 | 13 | 51 | 4 | 489953 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.97e-09 | 3 | 51 | 3 | 2413838 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 6098446 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.97e-09 | 3 | 51 | 3 | 21827821 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.97e-09 | 3 | 51 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.97e-09 | 3 | 51 | 3 | 2436036 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.97e-09 | 3 | 51 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.97e-09 | 3 | 51 | 3 | 17223109 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 15299664 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 12527308 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 2414282 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 8413315 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 28659346 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.97e-09 | 3 | 51 | 3 | 7678001 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 25588701 | ||
| Pubmed | 4.06e-09 | 14 | 51 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 4.06e-09 | 14 | 51 | 4 | 8001974 | |
| Pubmed | 4.06e-09 | 14 | 51 | 4 | 2902233 | ||
| Pubmed | 7.37e-09 | 16 | 51 | 4 | 2571572 | ||
| Pubmed | 7.37e-09 | 16 | 51 | 4 | 10842072 | ||
| Pubmed | 9.62e-09 | 17 | 51 | 4 | 25410786 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 1.19e-08 | 4 | 51 | 3 | 8543783 | |
| Interaction | AMY2B interactions | 1.70e-06 | 10 | 50 | 3 | int:AMY2B | |
| Interaction | TNFRSF19 interactions | 8.97e-06 | 53 | 50 | 4 | int:TNFRSF19 | |
| Interaction | TRIM28 interactions | ZNF430 ZNF100 ZNF562 ZNF728 EHMT1 ZNF721 ZNF736 ZNF101 ZNF224 ZNF227 ZNF112 ZNF284 ZNF248 ZNF445 | 9.04e-06 | 1474 | 50 | 14 | int:TRIM28 |
| Interaction | HTN3 interactions | 5.57e-05 | 30 | 50 | 3 | int:HTN3 | |
| Interaction | LTBP2 interactions | 5.85e-05 | 85 | 50 | 4 | int:LTBP2 | |
| Interaction | LRP1B interactions | 5.85e-05 | 85 | 50 | 4 | int:LRP1B | |
| Interaction | NOTCH2 interactions | 7.83e-05 | 423 | 50 | 7 | int:NOTCH2 | |
| Cytoband | 1p21 | 5.78e-11 | 24 | 51 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.35e-07 | 107 | 51 | 5 | chr1p21 | |
| Cytoband | 19p12 | 3.22e-06 | 90 | 51 | 4 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.08e-05 | 122 | 51 | 4 | chr19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.77e-05 | 1192 | 51 | 8 | chr19q13 | |
| Cytoband | 19q13.2 | 8.22e-04 | 164 | 51 | 3 | 19q13.2 | |
| Cytoband | 19p13.2 | 2.14e-03 | 229 | 51 | 3 | 19p13.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF430 CTCFL ZNF100 ZNF562 ZNF628 ZNF155 ZNF728 ZNF875 ZNF205 ZNF431 ZNF721 ZNF736 ZNF101 ZNF224 ZNF225 ZNF227 ZSCAN25 ZNF112 ZNF491 ZNF284 ZNF248 ZIC3 ZNF445 | 4.35e-22 | 718 | 41 | 23 | 28 |
| GeneFamily | Low density lipoprotein receptors | 3.05e-06 | 13 | 41 | 3 | 634 | |
| Coexpression | BERGER_MBD2_TARGETS | 1.13e-06 | 11 | 51 | 3 | MM905 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 1.22e-06 | 41 | 51 | 4 | MM698 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 5.72e-06 | 60 | 51 | 4 | MM654 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 1.78e-05 | 166 | 51 | 5 | MM563 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 1.96e-05 | 27 | 51 | 3 | MM643 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 7.75e-05 | 116 | 51 | 4 | MM1240 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.01e-04 | 239 | 51 | 5 | MM1274 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.21e-04 | 399 | 51 | 6 | M41172 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 1.28e-04 | 132 | 51 | 4 | MM470 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 1.60e-04 | 54 | 51 | 3 | MM889 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.74e-04 | 143 | 51 | 4 | MM1056 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.86e-04 | 432 | 51 | 6 | M41149 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 1.89e-04 | 57 | 51 | 3 | MM527 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 2.44e-04 | 289 | 51 | 5 | MM1238 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-06 | 168 | 51 | 5 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.24e-13 | 6 | 49 | 5 | CID003083414 | |
| Drug | R 623 | 2.24e-13 | 6 | 49 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 2.24e-13 | 6 | 49 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.24e-13 | 6 | 49 | 5 | CID000127364 | |
| Drug | CNP-G3 | 2.24e-13 | 6 | 49 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 7.83e-13 | 7 | 49 | 5 | CID000174858 | |
| Drug | BG5P | 7.83e-13 | 7 | 49 | 5 | CID003082752 | |
| Drug | desethylaprophen | 2.09e-12 | 8 | 49 | 5 | CID000163919 | |
| Drug | azintamide | 2.09e-12 | 8 | 49 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 4.68e-12 | 9 | 49 | 5 | CID000194237 | |
| Drug | trestatin A | 4.68e-12 | 9 | 49 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 9.35e-12 | 10 | 49 | 5 | CID000485275 | |
| Drug | Glc)4 | 9.35e-12 | 10 | 49 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 9.35e-12 | 10 | 49 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 9.35e-12 | 10 | 49 | 5 | CID000118008 | |
| Drug | validamycin D | 1.71e-11 | 11 | 49 | 5 | CID000166726 | |
| Drug | FG5P | 1.71e-11 | 11 | 49 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.71e-11 | 11 | 49 | 5 | CID000127309 | |
| Drug | HgI2 | 1.71e-11 | 11 | 49 | 5 | CID000024485 | |
| Drug | 2C KM | 1.71e-11 | 11 | 49 | 5 | CID009549196 | |
| Drug | 2-nitropropyl acetate | 1.89e-11 | 4 | 49 | 4 | CID013573844 | |
| Drug | N-PMT | 1.89e-11 | 4 | 49 | 4 | CID000194224 | |
| Drug | Dembrexine | 1.89e-11 | 4 | 49 | 4 | CID000072009 | |
| Drug | g lw | 1.89e-11 | 4 | 49 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 1.89e-11 | 4 | 49 | 4 | CID003482066 | |
| Drug | beta-santalene | 1.89e-11 | 4 | 49 | 4 | CID000010534 | |
| Drug | SAIB-SG | 1.89e-11 | 4 | 49 | 4 | CID002735139 | |
| Drug | azaprophen | 2.93e-11 | 12 | 49 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 4.75e-11 | 13 | 49 | 5 | CID000197426 | |
| Drug | isoacarbose | 4.75e-11 | 13 | 49 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 7.38e-11 | 14 | 49 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 7.38e-11 | 14 | 49 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 7.38e-11 | 14 | 49 | 5 | CID000012074 | |
| Drug | actinidine | 9.45e-11 | 5 | 49 | 4 | CID000068231 | |
| Drug | Deposiston | 9.45e-11 | 5 | 49 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 9.45e-11 | 5 | 49 | 4 | CID010358258 | |
| Drug | 2TAA | 9.45e-11 | 5 | 49 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 9.45e-11 | 5 | 49 | 4 | CID006449879 | |
| Drug | silver perchlorate | 9.45e-11 | 5 | 49 | 4 | CID000024562 | |
| Drug | lunularic acid | 9.45e-11 | 5 | 49 | 4 | CID000161413 | |
| Drug | himachalene | 9.45e-11 | 5 | 49 | 4 | CID000015095 | |
| Drug | AC1L4DZ4 | 9.45e-11 | 5 | 49 | 4 | CID000155287 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.11e-10 | 15 | 49 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 1.61e-10 | 16 | 49 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.61e-10 | 16 | 49 | 5 | CID003085308 | |
| Drug | 2-amino-6-picoline | 2.83e-10 | 6 | 49 | 4 | CID000015765 | |
| Drug | phenol blue | 2.83e-10 | 6 | 49 | 4 | CID000075078 | |
| Drug | Gu-4 | 2.83e-10 | 6 | 49 | 4 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.83e-10 | 6 | 49 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 2.83e-10 | 6 | 49 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.83e-10 | 6 | 49 | 4 | CID000092801 | |
| Drug | AC1OAGH8 | 2.83e-10 | 6 | 49 | 4 | CID006857368 | |
| Drug | vermella | 2.83e-10 | 6 | 49 | 4 | CID000203726 | |
| Drug | hymenin | 2.83e-10 | 6 | 49 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.83e-10 | 6 | 49 | 4 | CID000011615 | |
| Drug | trimitan | 3.14e-10 | 18 | 49 | 5 | CID000005561 | |
| Drug | aprophen | 3.14e-10 | 18 | 49 | 5 | CID000071128 | |
| Drug | 3KBG5CNP | 6.59e-10 | 7 | 49 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 6.59e-10 | 7 | 49 | 4 | CID000071762 | |
| Drug | Paramax | 6.59e-10 | 7 | 49 | 4 | CID000156411 | |
| Drug | methyl blue | 6.59e-10 | 7 | 49 | 4 | CID011969534 | |
| Drug | amino-methyl | 6.59e-10 | 7 | 49 | 4 | CID000142005 | |
| Drug | AC1L3XPY | 7.42e-10 | 21 | 49 | 5 | CID000124005 | |
| Drug | Bz-C | 9.59e-10 | 22 | 49 | 5 | CID000001511 | |
| Drug | maltosaccharide | 9.59e-10 | 22 | 49 | 5 | CID005461034 | |
| Drug | boric acid gel | 1.32e-09 | 8 | 49 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.32e-09 | 8 | 49 | 4 | CID005317411 | |
| Drug | theodrenaline | 1.32e-09 | 8 | 49 | 4 | CID000071857 | |
| Drug | N-vinylcaprolactam | 1.32e-09 | 8 | 49 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.32e-09 | 8 | 49 | 4 | CID000146692 | |
| Drug | acrinor | 1.32e-09 | 8 | 49 | 4 | CID005489637 | |
| Drug | rhodanile blue | 1.32e-09 | 8 | 49 | 4 | CID000073372 | |
| Drug | NSC300622 | 1.32e-09 | 8 | 49 | 4 | CID000028426 | |
| Drug | Panose B | 1.54e-09 | 24 | 49 | 5 | CID000439297 | |
| Drug | CID439354 | 1.92e-09 | 25 | 49 | 5 | CID000439354 | |
| Drug | Atonik | 2.37e-09 | 9 | 49 | 4 | CID000069471 | |
| Drug | GSAD | 2.37e-09 | 9 | 49 | 4 | CID009909127 | |
| Drug | GU-3 | 2.37e-09 | 9 | 49 | 4 | CID000448687 | |
| Drug | zingiberene | 2.37e-09 | 9 | 49 | 4 | CID000092776 | |
| Drug | H 187 | 2.37e-09 | 9 | 49 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 2.37e-09 | 9 | 49 | 4 | CID000024864 | |
| Drug | fuchsin | 2.38e-09 | 26 | 49 | 5 | CID000012447 | |
| Drug | 4-APP | 3.67e-09 | 61 | 49 | 6 | CID000075420 | |
| Drug | I ZE | 3.94e-09 | 10 | 49 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 3.94e-09 | 10 | 49 | 4 | CID000012135 | |
| Drug | CG-120 | 3.94e-09 | 10 | 49 | 4 | CID000171403 | |
| Drug | naphthalene-1,3,6,8-tetrol | 3.94e-09 | 10 | 49 | 4 | CID000440202 | |
| Drug | eicosa-11,14-dienoic acid | 3.94e-09 | 10 | 49 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 3.94e-09 | 10 | 49 | 4 | CID000126789 | |
| Drug | mannan | 4.48e-09 | 63 | 49 | 6 | CID000000870 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 5.12e-09 | 30 | 49 | 5 | CID005373003 | |
| Drug | AMO-1618 | 6.18e-09 | 11 | 49 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 6.18e-09 | 11 | 49 | 4 | CID000430710 | |
| Drug | Tempamine | 6.18e-09 | 11 | 49 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 6.18e-09 | 11 | 49 | 4 | CID000164608 | |
| Drug | Folin Marenzi reagent | 7.21e-09 | 32 | 49 | 5 | CID000452313 | |
| Drug | B5-9 | 7.21e-09 | 32 | 49 | 5 | CID003001978 | |
| Drug | R625 | 8.49e-09 | 33 | 49 | 5 | CID000072375 | |
| Drug | chitosan | 9.25e-09 | 12 | 49 | 4 | CID000071853 | |
| Drug | Avenin | 9.25e-09 | 12 | 49 | 4 | CID000095924 | |
| Disease | alpha-amylase 1 measurement | 7.72e-10 | 9 | 48 | 4 | EFO_0801371 | |
| Disease | free cholesterol in small LDL measurement | 8.94e-05 | 53 | 48 | 3 | EFO_0022271 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.33e-04 | 14 | 48 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.68e-04 | 15 | 48 | 2 | EFO_0007804, GO_0036273 | |
| Disease | apolipoprotein B measurement | 6.92e-04 | 663 | 48 | 6 | EFO_0004615 | |
| Disease | Coronary heart disease | 6.99e-04 | 24 | 48 | 2 | C0010068 | |
| Disease | serum metabolite measurement | 7.92e-04 | 945 | 48 | 7 | EFO_0005653 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 8.21e-04 | 26 | 48 | 2 | OBA_2045194 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 8.21e-04 | 26 | 48 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.31e-03 | 132 | 48 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.41e-03 | 34 | 48 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | response to cytosine arabinoside | 1.49e-03 | 35 | 48 | 2 | EFO_0005655 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.66e-03 | 37 | 48 | 2 | EFO_0022281 | |
| Disease | response to radiation, prostate carcinoma, erectile dysfunction | 1.66e-03 | 37 | 48 | 2 | EFO_0001663, EFO_0004234, GO_0009314 | |
| Disease | aspirin use measurement | 1.85e-03 | 39 | 48 | 2 | EFO_0007013 | |
| Disease | cholesterol in very small VLDL measurement | 1.94e-03 | 40 | 48 | 2 | EFO_0022231 | |
| Disease | free cholesterol in medium LDL measurement | 1.94e-03 | 40 | 48 | 2 | EFO_0022268 | |
| Disease | Childhood Medulloblastoma | 2.24e-03 | 43 | 48 | 2 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.24e-03 | 43 | 48 | 2 | C1275668 | |
| Disease | Medullomyoblastoma | 2.24e-03 | 43 | 48 | 2 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.24e-03 | 43 | 48 | 2 | C0751291 | |
| Disease | triglycerides in large LDL measurement | 2.24e-03 | 43 | 48 | 2 | EFO_0022319 | |
| Disease | Adult Medulloblastoma | 2.24e-03 | 43 | 48 | 2 | C0278876 | |
| Disease | concentration of large LDL particles measurement | 2.35e-03 | 44 | 48 | 2 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 2.35e-03 | 44 | 48 | 2 | EFO_0022225 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.45e-03 | 45 | 48 | 2 | EFO_0022236 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.56e-03 | 46 | 48 | 2 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 2.67e-03 | 47 | 48 | 2 | DOID:9074 (is_marker_for) | |
| Disease | free cholesterol in very small VLDL measurement | 2.67e-03 | 47 | 48 | 2 | EFO_0022275 | |
| Disease | total lipids in lipoprotein particles measurement | 2.79e-03 | 48 | 48 | 2 | EFO_0022309 | |
| Disease | phospholipids in medium LDL measurement | 2.90e-03 | 49 | 48 | 2 | EFO_0022183 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.90e-03 | 49 | 48 | 2 | EFO_0022256 | |
| Disease | Medulloblastoma | 3.02e-03 | 50 | 48 | 2 | C0025149 | |
| Disease | free cholesterol in LDL measurement | 3.02e-03 | 50 | 48 | 2 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 3.14e-03 | 51 | 48 | 2 | EFO_0022176 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 3.14e-03 | 51 | 48 | 2 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 3.14e-03 | 51 | 48 | 2 | EFO_0022285 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKCSKCGKGFSRWIN | 546 | Q8NI51 | |
| KDVIGDEICCWSFYG | 201 | Q13829 | |
| YSGWDFNDGKCKTGS | 146 | P0DTE7 | |
| YSGWDFNDGKCKTGS | 146 | P0DTE8 | |
| KVRCFFCYGGLQSWK | 121 | Q96CA5 | |
| YSGWDFNDGKCKTGS | 146 | P0DUB6 | |
| WEDYSCVCDKGYLGI | 1891 | Q9NYQ6 | |
| YSGWDFNDGKCKTGS | 146 | P19961 | |
| WDCTYDGKAKRTCFR | 446 | Q9NR16 | |
| YSGWDFNDGKCKTGS | 146 | P04746 | |
| CSGDKLGDKYACWYQ | 41 | P01715 | |
| KCSCYEGWKLDVDGE | 1236 | Q9NZR2 | |
| YGVWSCEGCKAFFKR | 161 | Q92731 | |
| KFSVKCSCYEGWVLE | 1241 | Q07954 | |
| WEYEGFTKCSESCGG | 611 | Q8N6G6 | |
| KHCSNCGLYKWERDG | 831 | Q7L590 | |
| LGKCEIGWAYYCTGA | 161 | Q9Y693 | |
| DWGETCKGCAEKSDY | 146 | P55145 | |
| GKSDFCWCVDKDGRE | 1056 | Q14112 | |
| WSECSVTCGKGYKQR | 1621 | Q9P2N4 | |
| FWDIKGKLFSCRCGS | 1246 | Q9H9B1 | |
| RSVESCWYFGDGFCK | 91 | Q9P1P4 | |
| ACVAKYSGKWCRAAV | 806 | B5MCY1 | |
| GDKAVYCRCWRSKKF | 66 | Q9NZ45 | |
| GCTWKGTLKEYESCH | 111 | Q12933 | |
| CGFVCARAWTVKKGF | 186 | Q8IUA0 | |
| VCYWEECPREGKSFK | 296 | O60481 | |
| SYKCEECGKGFNWSS | 371 | Q8TF32 | |
| YKCEECGKGFNWSSA | 401 | Q8IYN0 | |
| YSGWKLCENCGEVFS | 121 | Q6V9R5 | |
| YKCGDCWKSFSRRQH | 431 | Q6NSZ9 | |
| SYKCEECGKAFGWSI | 656 | Q8TF20 | |
| KFKCCGGEDYRDWSK | 151 | O95858 | |
| YKCEECGKAFIWSSR | 536 | P0DKX0 | |
| KYIWCLDYKGGLFCS | 821 | O15040 | |
| PYNCKECGKSFRWAS | 371 | Q9UK10 | |
| YKCEECGKGFNWSST | 401 | Q9H8G1 | |
| YKCDACGKGFRWSSG | 861 | Q9UJU3 | |
| GEKRFWCQECGKTFT | 836 | P59923 | |
| KSYRCEQCGKGFSWH | 306 | O95201 | |
| YECTRCGKAFGWCSS | 366 | Q8IZC7 | |
| PYNCKECGKSFRWSS | 371 | Q12901 | |
| YKCEECGKGFSWRSN | 576 | Q86WZ6 | |
| EKRYECKQCGKAFSW | 156 | Q8N8L2 | |
| YVCRECGRGFTWKSN | 301 | P10072 | |
| PYNCKECGKSFRWAS | 371 | Q9NZL3 | |
| YKCDECGKGFSWSST | 596 | Q9NZL3 | |
| GEKTFECGECGKTFW | 376 | Q8NDW4 | |
| YKCEECGKGFRWAST | 511 | Q2VY69 | |
| PYKCEECGKASSWFS | 396 | B4DX44 | |
| YECGECGKSFRWSSR | 36 | Q5EBL2 | |
| DGKCISYKWVCDGSA | 36 | P01130 |